Literature DB >> 15509625

Prevalence of Sjögren's syndrome in ambulatory patients according to the American-European Consensus Group criteria.

J Sánchez-Guerrero1, M R Pérez-Dosal, F Cárdenas-Velázquez, A Pérez-Reguera, E Celis-Aguilar, A E Soto-Rojas, C Avila-Casado.   

Abstract

OBJECTIVE: To estimate the prevalence of Sjögren's syndrome (SS) in ambulatory patients attending a tertiary care centre, according to the American-European Consensus Group criteria, using a structured approach.
METHODS: Three hundred patients from rheumatology and internal medicine clinics were randomly chosen. During the screening phase, a face-to-face interview, a screening questionnaire, a Schirmer-I test and a wafer test were carried out in all patients. During the second phase, patients with positive screening had confirmatory tests including fluorescein staining test, non-stimulated whole salivary flow and autoantibody testing. Confirmatory tests were also done in 13 patients with negative screening. In the last phase, lip biopsy was proposed to those patients who met pre-established criteria.
RESULTS: Females constituted 79% of the study population. The mean age of the subjects was 42.8+/-15.7 yr. Two hundred and twenty patients (73%) had positive screening. Fifty-five (27%) out of 204 patients evaluated showed keratoconjunctivitis sicca and 28 (13%) out of 215 patients xerostomia. One hundred and sixty-eight patients met criteria for lip biopsy and it was performed in 80 subjects who accepted the procedure. Focal sialoadenitis was demonstrated in 39 patients (49%), but only 28 of them met criteria for SS. In total, 40 patients were classified as SS. The minimum prevalence of SS in the population studied was 13.3% (95% CI 9.5-17.1%). The structured approach used in this study allowed 24 (60%) undiagnosed cases of SS to be identified.
CONCLUSION: SS is common among ambulatory patients attending a tertiary care centre and in most of them it is undiagnosed.

Entities:  

Mesh:

Year:  2004        PMID: 15509625     DOI: 10.1093/rheumatology/keh455

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  The Sustained Effects on Tear Volume of Pilocarpine Hydrochloride in Gelatin by Hydrogel Administered by An Implant-mediated Drug Delivery System.

Authors:  Seunghee Cha; Hong-Kyun Kim; Hong-Seop Kho; Young-Seok Park
Journal:  Curr Drug Deliv       Date:  2017       Impact factor: 2.565

2.  [Sjögren's syndrome. Current aspects from a rheumatological point of view].

Authors:  C Tomiak; T Dörner
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 3.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

4.  Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice.

Authors:  Zhennan Lai; Hongen Yin; Javier Cabrera-Pérez; Maria C Guimaro; Sandra Afione; Drew G Michael; Patricia Glenton; Ankur Patel; William D Swaim; Changyu Zheng; Cuong Q Nguyen; Fred Nyberg; John A Chiorini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

5.  Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.

Authors:  K Jayakanthan; J Ramya; Santosh Kumar Mandal; P Sandhya; M Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2016-01-26       Impact factor: 2.980

Review 6.  Sjögren's syndrome: diagnosis and therapeutic challenges in the elderly.

Authors:  Kristine P Ng; David A Isenberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Comparison of telomere length and association with progenitor cell markers in lacrimal gland between Sjögren syndrome and non-Sjögren syndrome dry eye patients.

Authors:  Motoko Kawashima; Tetsuya Kawakita; Yoshiko Maida; Mizuka Kamoi; Yoko Ogawa; Shigeto Shimmura; Kenkichi Masutomi; Kazuo Tsubota
Journal:  Mol Vis       Date:  2011-05-27       Impact factor: 2.367

8.  Sjögren's, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series.

Authors:  Pulukool Sandhya; Debashish Danda; Simon Rajaratnam; Nihal Thomas
Journal:  Open Rheumatol J       Date:  2014-12-19

9.  Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms.

Authors:  Janett Riega-Torres; Guillermo Delgado-García; Julio César Salas-Alanís; Cassandra Skinner-Taylor; Lorena Pérez-Barbosa; Mario Garza-Elizondo; Celia Nohemí Sánchez-Domínguez; Luis Ángel Ceceñas-Falcón; Karim Mohamed-Noriega; Jesús Mohamed-Hamsho; David Vega-Morales
Journal:  Arch Rheumatol       Date:  2017-05-25       Impact factor: 1.472

10.  Preliminary Screening Questionnaire for Sjögren's Syndrome in the Rheumatology Setting.

Authors:  Kimberley Yu; Gui-Shuang Ying; Frederick B Vivino; John A Gonzales; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.